Search: WFRF:(Coresh Josef) >
Hyperkalemia After ...
Hyperkalemia After Initiating Renin-Angiotensin System Blockade : The Stockholm Creatinine Measurements (SCREAM) Project
-
- Bandak, Ghassan (author)
- Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA.
-
- Sang, Yingying (author)
- Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
-
- Gasparini, Alessandro (author)
- Karolinska Institutet,Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
-
show more...
-
- Chang, Alex R. (author)
- Geisinger Hlth Syst, Div Nephrol, Danville, PA USA.
-
- Ballew, Shoshana H. (author)
- Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
-
- Evans, Marie (author)
- Karolinska Institutet,Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
-
- Ärnlöv, Johan, 1970- (author)
- Högskolan Dalarna,Karolinska Institutet,Uppsala universitet,Kardiovaskulär epidemiologi,Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden.,Medicinsk vetenskap
-
- Lund, Lars H. (author)
- Karolinska Institutet,Karolinska Inst, Unit Cardiol, Dept Med, Stockholm, Sweden.
-
- Inker, Lesley A. (author)
- Tufts Med Ctr, Div Nephrol, Boston, MA USA.
-
- Coresh, Josef (author)
- Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
-
- Carrero, Juan-Jesus (author)
- Karolinska Institutet,Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
-
- Grams, Morgan E. (author)
- Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA.;Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
-
show less...
-
Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA. (creator_code:org_t)
- WILEY, 2017
- 2017
- English.
-
In: Journal of the American Heart Association. - : WILEY. - 2047-9980. ; 6:7
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://du.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- Background: Concerns about hyperkalemia limit the use of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARBs), but guidelines conflict regarding potassium-monitoring protocols. We quantified hyperkalemia monitoring and risks after ACE-I/ARB initiation and developed and validated a hyperkalemia susceptibility score.Methods and Results: We evaluated 69 426 new users of ACE-I/ARB therapy in the Stockholm Creatinine Measurements (SCREAM) project with medication initiation from January 1, 2007 to December 31, 2010, and follow-up for 1 year thereafter. Three fourths (76%) of SCREAM patients had potassium checked within the first year. Potassium >5 and >5.5 mmol/L occurred in 5.6% and 1.7%, respectively. As a comparison, we propensity-matched new ACE-I/ARB users to 20 186 new beta-blocker users in SCREAM: 64% had potassium checked. The occurrence of elevated potassium levels was similar between new beta-blocker and ACEI/ARB users without kidney disease; only at estimated glomerular filtration rate <60 mL/min per 1.73 m(2) were risks higher among ACE-I/ARB users. We developed a hyperkalemia susceptibility score that incorporated estimated glomerular filtration rate, baseline potassium level, sex, diabetes mellitus, heart failure, and the concomitant use of potassium-sparing diuretics in new ACE-I/ARB users; this score accurately predicted 1-year hyperkalemia risk in the SCREAM cohort (area under the curve, 0.845, 95% CI: 0.840-0.869) and in a validation cohort from the US-based Geisinger Health System (N=19 524; area under the curve, 0.818, 95% CI: 0.794-0.841), with good calibration.Conclusions: Hyperkalemia within the first year of ACE-I/ARB therapy was relatively uncommon among people with estimated glomerular filtration rate >60 mL/min per 1.73 m(2), but rates were much higher with lower estimated glomerular filtration rate. Use of the hyperkalemia susceptibility score may help guide laboratory monitoring and prescribing strategies.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Keyword
- angiotensin-converting enzyme inhibitors
- angiotensin receptor blockers
- angiotensin-converting enzyme inhibition
- chronic kidney disease
- hyperkalemia
- potassium
- risk score
- Hälsa och välfärd
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Bandak, Ghassan
-
Sang, Yingying
-
Gasparini, Aless ...
-
Chang, Alex R.
-
Ballew, Shoshana ...
-
Evans, Marie
-
show more...
-
Ärnlöv, Johan, 1 ...
-
Lund, Lars H.
-
Inker, Lesley A.
-
Coresh, Josef
-
Carrero, Juan-Je ...
-
Grams, Morgan E.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
- Articles in the publication
-
Journal of the A ...
- By the university
-
Uppsala University
-
Karolinska Institutet
-
Högskolan Dalarna